Insights

Strategic Partnerships DNDi actively collaborates with major humanitarian and research partners (MSF, WHO) and recently aligned with GARDP and MMV to pool expertise. This presents opportunities to offer complementary capabilities, funding-enabled collaboration models, and joint grant opportunities that align with their not-for-profit mission.

Nonprofit Funding Fit With a revenue range of 100M to 250M and a mission to deliver affordable treatments, DNDi seeks high-impact, cost-conscious solutions, grant-ready partnerships, and interoperable tech platforms that reduce R&D timelines and cost, particularly in neglected diseases research.

R&D Ecosystem Access DNDi runs over 40 projects and more than 20 clinical trials across neglected diseases, indicating ongoing demand for research services, clinical development support, regulatory consulting, and access to varied compound libraries or collaboration on open-source discovery initiatives.

Governance and Leadership Recent board expansions and leadership change, including the upcoming departure of the Executive Director, signal a period of strategic realignment and potential openness to new vendors, advisory services, or strategic consulting engagements aligned with their evolving priorities.

Open Innovation Networks Heralded initiatives like the Pandemic Response Box and cross-organizational partnerships suggest interest in open-access discovery platforms and shared resource programs. There is potential to offer platform licenses, data collaboration tools, and research accelerators that fit DNDi’s collaborative model.

Similar companies to Drugs for Neglected Diseases initiative (DNDi)

Drugs for Neglected Diseases initiative (DNDi) Tech Stack

Drugs for Neglected Diseases initiative (DNDi) uses 8 technology products and services including iCIMS, Adobe Creative Cloud, Power BI, and more. Explore Drugs for Neglected Diseases initiative (DNDi)'s tech stack below.

Media & News

Drugs for Neglected Diseases initiative (DNDi)'s Email Address Formats

Drugs for Neglected Diseases initiative (DNDi) uses at least 3 email formats:
Drugs for Neglected Diseases initiative (DNDi) Email FormatsExamplePercentage
FLast@dndi.orgJDoe@dndi.org
98%
LFirst@dndi.orgDJohn@dndi.org
1%
FMiddleLast@dndi.orgJMichaelDoe@dndi.org
1%

Frequently Asked Questions

What is Drugs for Neglected Diseases initiative (DNDi)'s phone number?

Minus sign iconPlus sign icon
You can contact Drugs for Neglected Diseases initiative (DNDi)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Drugs for Neglected Diseases initiative (DNDi)'s official website and social media links?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi)'s official website is dndi.org and has social profiles on LinkedIn and Crunchbase.

How much revenue does Drugs for Neglected Diseases initiative (DNDi) generate?

Minus sign iconPlus sign icon
As of August 2026, Drugs for Neglected Diseases initiative (DNDi)'s annual revenue is estimated to be $100M - $250M.

What is Drugs for Neglected Diseases initiative (DNDi)'s NAICS code?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi)'s NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Drugs for Neglected Diseases initiative (DNDi) have currently?

Minus sign iconPlus sign icon
As of August 2026, Drugs for Neglected Diseases initiative (DNDi) has approximately 431 employees across 5 continents, including Europe, Asia and Africa. Key team members include Chief Of Staff: A. F., Head Of Hr & Organisation: S. V. and Head Of Drug Discovery - Member Of The Senior Leadership Team: E. C. Explore Drugs for Neglected Diseases initiative (DNDi)'s employee directory with LeadIQ.

What industry does Drugs for Neglected Diseases initiative (DNDi) belong to?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi) operates in the Research Services industry.

What technology does Drugs for Neglected Diseases initiative (DNDi) use?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi)'s tech stack includes iCIMS, Adobe Creative Cloud, Power BI, WordPress, Salesforce, ChatGPT, Sprout Social and Microsoft Teams.

What is Drugs for Neglected Diseases initiative (DNDi)'s email format?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi)'s email format typically follows the pattern of FLast@dndi.org. Find more Drugs for Neglected Diseases initiative (DNDi) email formats with LeadIQ.

When was Drugs for Neglected Diseases initiative (DNDi) founded?

Minus sign iconPlus sign icon
Drugs for Neglected Diseases initiative (DNDi) was founded in 2003.
Drugs for Neglected Diseases initiative (DNDi) logo

Drugs for Neglected Diseases initiative (DNDi)

Research ServicesGeneva, Switzerland201-500 Employees

DNDi, or the Drugs for Neglected Diseases initiative, is an international, not-for-profit research and development organization based in Geneva, Switzerland. It focuses on discovering, developing, and delivering treatments for neglected diseases that affect patients around the world, aiming for affordable and patient-friendly options. Its work encompasses a broad portfolio of projects and clinical trials, addressing conditions such as Chagas disease, sleeping sickness, leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue, often in partnership with other organizations and research institutions. The organization positions itself within the research services space, collaborating with partners to accelerate the development of life-saving therapies for underserved populations. Recent activities of note include collaborations with global health partners to strengthen coordination and accelerate translational work, reflecting its ongoing commitment to expanding access to treatments through a not-for-profit model.

Section iconCompany Overview

Phone number
Website
dndi.org
NAICS Code
5417 - Scientific Research and Development Services
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $100M - $250M

    Drugs for Neglected Diseases initiative (DNDi)'s revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.